Coverage
-
March 27, 2023
A federal judge has dismissed a proposed class action against Johnson & Johnson over allegations that consumers were misled to believe "rapid release" Tylenol gelcaps work faster than less expensive options, saying there is no foreseeable risk of harm.
4 other articles on this case.
View all »